Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06555744
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-13
Brief Title:
A Study of ZW191 in Participants With Solid Tumors
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase 1 Open-label Multicenter Study to Assess the Safety Tolerability Pharmacokinetics and Preliminary Anti-tumor Activity of Ascending Doses of a Folate Receptor Alpha Antibody Drug Conjugate ZW191 in Participants With Advanced Solid Tumors
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to find out if ZW191 is safe and can treat participants with advanced cancers including ovarian endometrial and non-small cell lung cancers
Detailed Description:
Part 1 of the study will evaluate the safety and tolerability of ZW191 Part 2 of the study will further evaluate safety and explore the potential anti-tumor activity of ZW191
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None